Compound Evidence File
#EC-2026-0726
Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC)
Filed under Injectable Oils. The bureau holds 124 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
44 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 18 Jan 2026 | 11 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Apr 2026 | 7 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Apr 2026 | 19 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Jan 2026 | 22 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Feb 2026 | 10 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Mar 2026 | 2 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Feb 2026 | 13 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Jun 2026 | 12 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Nov 2025 | 18 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 20 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Jul 2026 | 10 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 24 Jul 2026 | 8 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 23 May 2026 | 17 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Jun 2026 | 22 Jun 2026 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 10.0 | 10.0 | 10.0 | 17 Dec 2024 | 17 Dec 2024 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 | 16 Mar 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 23 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 1 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 3 May 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 7 May 2026 | 23 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Jun 2026 | 2 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Nov 2025 | 23 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Mar 2026 | 15 Jun 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 9.3 | 9.3 | 9.3 | 14 Jan 2025 | 14 Jan 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 9.2 | 8.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 9.0 | 9.0 | 9.0 | 6 May 2025 | 6 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.9 | 7.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.9 | 8.9 | 8.9 | 13 Feb 2025 | 13 Feb 2025 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 | 21 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.3 | 6.8 | 9.8 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.2 | 7.3 | 8.7 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.1 | 6.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 2 | 7.7 | 7.6 | 7.8 | 16 Mar 2025 | 19 Jan 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 7.5 | 7.5 | 7.5 | 8 Jul 2025 | 8 Jul 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 6.8 | 6.8 | 6.8 | 8 Jul 2025 | 8 Jul 2025 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 | 8 Jul 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 5 | 6.5 | 5.4 | 7.5 | 2 Jul 2025 | 24 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jun 2025 | 3 Jun 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 3 | 5.4 | 2.7 | 8.4 | 16 Mar 2025 | 24 May 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 4.5 | 4.5 | 4.5 | 11 Jun 2025 | 11 Jun 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 2.3 | 2.3 | 2.3 | 27 Feb 2025 | 27 Feb 2025 |
Open any subject to view the batch-level evidence for Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) alone.